Microalbuminuria is independently associated with arterial stiffness and vascular inflammation but not with carotid intima-media thickness in patients with newly diagnosed type 2 diabetes or essential hypertension

Journal of Korean Medical Science

Volumn 28, Issue 2, 2013, Pages 252-260

  Shin, Dong Il ^a   Seung, Ki Bae ^a,b   Yoon, Hye Eun ^a   Hwang, Byung Hee ^b   Seo, Suk Min ^a   Shin, Seok Joon ^a   Kim, Pum Joon ^b   Chang, Kiyuk ^b   Baek, Sang Hong ^b  

^a The Catholic University of Korea   (South Korea)

^b The Catholic University of Korea   (South Korea)

Author keywords

Albuminuria; Carotid intima media thickness; Inflammation; Vascular stiffness

Indexed keywords

C REACTIVE PROTEIN; CREATININE;

ALBUMINURIA; AREA UNDER THE CURVE; ARTERIAL STIFFNESS; ARTERIAL WALL THICKNESS; ARTICLE; CARDIOVASCULAR DISEASE; FEMALE; HUMAN; HYPERTENSION; INFLAMMATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; RISK; RISK FACTOR; STATISTICAL MODEL; URINE;

ALBUMINURIA; CAROTID INTIMA-MEDIA THICKNESS; INFLAMMATION; VASCULAR STIFFNESS;

ALBUMINURIA; AREA UNDER CURVE; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CAROTID INTIMA-MEDIA THICKNESS; CREATININE; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPERTENSION; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; RISK FACTORS; VASCULAR STIFFNESS;

EID: 84874800488     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2013.28.2.252     Document Type: Article

References (29)

1. Rosenson RS, Fioretto P, Dodson PM. Does microvascular disease predict macrovascular events in type 2 diabetes? Atherosclerosis 2011; 218: 13-8.
2. Kim JH, Kim DJ, Jang HC, Choi SH. Epidemiology of micro- and macrovascular complications of type 2 diabetes in Korea. Diabetes Metab J 2011; 35: 571-7.
3. Mulè G, Cottone S, Vadalà A, Volpe V, Mezzatesta G, Mongiovì R, Piazza G, Nardi E, Andronico G, Cerasola G. Relationship between albumin excretion rate and aortic stiffness in untreated essential hypertensive patients. J Intern Med 2004; 256: 22-9.
4. Kim BJ, Lee HA, Kim NH, Kim MW, Kim BS, Kang JH. The association of albuminuria, arterial stiffness, and blood pressure status in nondiabetic, nonhypertensive individuals. J Hypertens 2011; 29: 2091-8.
5. Mulè G, Cottone S, Cusimano P, Riccobene R, Palermo A, Geraci C, Nardi E, Bellavia T, Foraci AC, Cerasola G. The association of microalbuminuria with aortic stiffness is independent of C-reactive protein in essential hypertension. Am J Hypertens 2009; 22: 1041-7.
6. Ishimura E, Taniwaki H, Tsuchida T, Obatake N, Emoto M, Shoji T, Shioi A, Inaba M, Nishizawa Y. Urinary albumin excretion associated with arterial wall stiffness rather than thickness in type 2 diabetic patients. J Nephrol 2007; 20: 204-11.
7. Jia EZ, An FH, Liu P, Li F, Mao HW, Cui WJ, Xu HY. Relationship between brachial-ankle pulse wave velocity and cardiovascular risk factors: a multi-ethnic study. Intern Med 2012; 51: 537-43.
8. Cardoso CR, Marques CE, Leite NC, Salles GF. Factors associated with carotid intima-media thickness and carotid plaques in type 2 diabetic patients. J Hypertens 2012; 30: 940-7.
9. Karalliedde J, Viberti G. Microalbuminuria and cardiovascular risk. Am J Hypertens 2004; 17: 986-93.
10. Chae HW, Shin JI, Kwon AR, Kim HS, Kim DH. Spot urine albumin to creatinine ratio and serum cystatin C are effective for detection of diabetic nephropathy in childhood diabetic patients. J Korean Med Sci 2012; 27: 784-7.
11. Ishikawa T, Hashimoto J, Morito RH, Hanazawa T, Aikawa T, Hara A, Shintani Y, Metoki H, Inoue R, Asayama K, et al. Association of microalbuminuria with brachial-ankle pulse wave velocity: the Ohasama study. Am J Hypertens 2008; 21: 413-8.
12. Huang Y, Chen Y, Xu M, Gu W, Bi Y, Li X, Ning G. Low-grade albuminuria is associated with carotid intima-media thickness in Chinese type 2 diabetic patients. J Clin Endocrinol Metab 2010; 95: 5122-8.
13. Keech AC, Grieve SM, Patel A, Griffiths K, Skilton M, Watts GF, Marwick TH, Groshens M, Celermajer DS. Urinary albumin levels in the normal range determine arterial wall thickness in adults with type 2 diabetes: a FIELD substudy. Diabet Med 2005; 22: 1558-65.
14. Choi SW, Yun WJ, Kim HY, Lee YH, Kweon SS, Rhee JA, Choi JS, Shin MH. Association between albuminuria, carotid atherosclerosis, arterial stiffness, and peripheral arterial disease in Korean type 2 diabetic patients. Kidney Blood Press Res 2010; 33: 111-8.
15. Gavin JR, Alberti KGMM, Davidson MB, DeFronzo RA, Drash A, Gabbe SG, Genuth S, Harris MI, Kahn R, Keen H, et al. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997; 20: 1183-97.
16. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 2003; 289: 2560-72.
17. An HR, Park S, Yoo TH, Kang SW, Ryu JH, Lee YK, Yu M, Ryu DR, Kim SJ, Kang DH, et al. Non-dipper status and left ventricular hypertrophy as predictors of incident chronic kidney disease. J Korean Med Sci 2011; 26: 1185-90.
18. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41.
19. Ahn MS, Kim JY, Youn YJ, Kim SY, Koh SB, Lee K, Yoo BS, Lee SH, Yoon J, Park JK, et al. Cardiovascular parameters correlated with metabolic syndrome in a rural community cohort of Korea: the ARIRANG Study. J Korean Med Sci 2010; 25: 1045-52.
20. Abdelhafiz AH, Ahmed S, El Nahas M. Microalbuminuria: marker or maker of cardiovascular disease. Nephron Exp Nephrol 2011; 119: e6-10.
21. Culleton BF, Larson MG, Wilson PW, Evans JC, Parfrey PS, Levy D. Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency. Kidney Int 1999; 56: 2214-9.
22. Yokoyama H, Sone H, Saito K, Yamada D, Honjo J, Haneda M. Flowmediated dilation is associated with microalbuminuria independent of cardiovascular risk factors in type 2 diabetes: interrelations with arterial thickness and stiffness. J Atheroscler Thromb 2011; 18: 744-52.
23. Kim ES, Moon SD, Kim HS, Lim DJ, Cho JH, Kwon HS, Ahn CW, Yoon KH, Kang MI, Cha BY, et al. Diabetic peripheral neuropathy is associated with increased arterial stiffness without changes in carotid intimamedia thickness in type 2 diabetes. Diabetes Care 2011; 34: 1403-5.
24. Cheung N, Wang JJ, Rogers SL, Brancati F, Klein R, Sharrett AR, Wong TY, ARIC (Atherosclerosis Risk In Communities) Study Investigators. Diabetic retinopathy and risk of heart failure. J Am Coll Cardiol 2008; 51: 1573-8.
25. Zizek B, Poredos P. Dependence of morphological changes of the carotid arteries on essential hypertension and accompanying risk factors. Int Angiol 2002; 21: 70-7.
26. Tomiyama H, Yamashina A. Non-invasive vascular function tests: their pathophysiological background and clinical application. Circ J 2010; 74: 24-33.
27. Tsioufis C, Dimitriadis K, Taxiarchou E, Vasiliadou C, Chartzoulakis G, Tousoulis D, Manolis A, Stefanadis C, Kallikazaros I. Diverse associations of microalbuminuria with C-reactive protein, interleukin-18, and soluble CD 40 ligand in male essential hypertensive subjects. Am J Hypertens 2006; 19: 462-6.
28. Kshirsagar AV, Bomback AS, Bang H, Gerber LM, Vupputuri S, Shoham DA, Mazumdar M, Ballantyne CM, Paparello JJ, Klemmer PJ. Association of C-reactive protein and microalbuminuria (from the National Health and Nutrition Examination Survey, 1999 to 2004). Am J Cardiol 2008; 101: 401-6.
29. Ruilope L, Izzo J, Haller H, Waeber B, Oparil S, Weber M, Bakris G, Sowers J. Prevention of microalbuminuria in patients with type 2 diabetes: what do we know? J Clin Hypertens (Greenwich) 2010; 12: 422-30.